STOCK TITAN

Immunic: Morgan Stanley reports 5.2% passive stake

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

Immunic, Inc. (IMUX) was the subject of Morgan Stanley’s report of beneficial ownership of 704,244 shares of common stock, equal to 5.2% of the class. Morgan Stanley reported shared voting power over 702,419 shares and shared dispositive power over 704,244 shares, with zero sole voting or dispositive power. The reported figures cover certain Morgan Stanley operating units and exclude units whose ownership is disaggregated under the referenced SEC release.

Beneficial ownership 704,244 shares Morgan Stanley reported this as 5.2% of Immunic, Inc. common stock.
Class ownership 5.2% Percentage represented by Morgan Stanley’s reported beneficial ownership.
Shared voting power 702,419 shares Reported by Morgan Stanley.
Shared dispositive power 704,244 shares Reported by Morgan Stanley.
beneficially owned regulatory
"Amount beneficially owned: 704,244.00"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
Shared Voting Power regulatory
"Shared Voting Power 702,419.00"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
Shared Dispositive Power regulatory
"Shared Dispositive Power 704,244.00"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many IMUX shares did Morgan Stanley report beneficially owning?

Morgan Stanley reported beneficial ownership of 704,244 Immunic, Inc. common shares, equal to 5.2% of the class.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





4525EP200

(CUSIP Number)
09/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G



Morgan Stanley
Signature:Claire Gordon
Name/Title:Authorized Signatory, Morgan Stanley
Date:11/13/2026

Keep reading